
Opinion|Videos|January 8, 2025
Long-Term Considerations for PBC Treatment Options
Panelists discuss how sustained treatment success in primary biliary cholangitis (PBC) requires regular monitoring of biochemical response markers, assessing patient adherence, managing potential adverse effects, and making timely adjustments to treatment strategies based on individual patient responses to seladelpar and elafibranor.
Advertisement
Episodes in this series

Video content above is prompted by the following:
- As new data emerge regarding the durability of response with seladelpar and elafibranor, what are the key long-term considerations for maintaining treatment efficacy in PBC?
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Pharmacy Times
1
AHA/ACC CKM Guideline Formally Endorses GLP-1 Therapies for Kidney, Heart Protection
2
GLP-1s and Muscle Loss: The Conversation Pharmacists Are Not Having, But Should Be
3
McKesson ideaShare 2026: Building Specialty and Infusion Capacity From the Ground Up
4
McKesson ideaShare 2026: Recapping Key Insights from Denver
5


















































































































